In reference to topical pimecrolimus 1% for the treatment of pruritic external auditory canals [1]

Laryngoscope

Volumn 117, Issue 7, 2007, Pages 1319-

  Acar, Baran ^a   Sahin, Yasemin ^a  

^a Kecioren Research and Training Hospital ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PIMECROLIMUS;

CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; EXTERNAL AUDITORY CANAL; HUMAN; LETTER; PRIORITY JOURNAL; PRURITUS; RATING SCALE; SYMPTOM; SYSTEMIC THERAPY; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EAR, EXTERNAL; HUMANS; PRURITUS; TACROLIMUS;

EID: 34347348326     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3180621136     Document Type: Letter

References (3)

1. Djalilia HR, Memar O. Topical pimecrolimus 1% for the treatment of pruritic external auditory canals. Laryngoscope 2006;116:1809-12.
2. Ophir D, Fink A, Eliraz A, Tabachnick E, Bentwich Z. Allergen-induced leukotriene production by nasal mukoza and peripheral blood leucocytes. Arch Otolaryngol Head Neck Surg 1988;114:522-524.
3. King WP. Allergic disorders in the otolaryngologic practice: symposium on immunology and allergy. Otolaryngol Clin North Am 1985;18:677-690.